The size of the North American blood flow measurement devices market is forecasted to grow USD 323.12 million by 2027 from USD 206.20 million in 2022, registering a CAGR of 9.4% between 2022 to 2027.
The diabetic epidemic, along with rising cases of cardiovascular diseases, an influx of VC funding, augmenting the geriatric population, and technological advancements are the factors fuelling the growth of this market.
Increasing usage of these devices in chronic disease treatments, majorly in heart-related disorders, and growing demand for minimally invasive surgeries accelerates the market demand in the North American region. An estimated 2 out of every 5 Americans have diabetes as per National Diabetes Statistics Report, 2017. Technological advancements in this field are another significant factor contributing to the growth of the market. Growing healthcare expenditure and increasing enrollments in blood flow monitors are further expected to favor the blood flow measurement devices market in North America. Secondary driving factors include the rising number of organ transplants and technological advancements.
Strict regulatory frameworks and cumbersome bureaucratic procedures are the primary inhibitors of the market. Costs associated with these days are not affordable to everybody in the countries of North American countries, which is projected to show a little negative impact on the market.
This research report on the North American Blood Flow Measurement Devices Market has been segmented and sub-segmented into the following categories:
By Product:
By Application:
By Country:
Regionally, North America accounted for the largest share in the North American blood flow measurement devices market and registered a 40% share in the global market in 2019. The United States is the leading player in this region. The rising geriatric population, increased prevalence of hypertension, increased funding, and the majority of cardiovascular diseases are some of the factors that are attributable to the observable trend mentioned above.
U.S and Canada are the two countries accounting significant share in the North American blood flow measurement devices market. The United States is dominating the North American market with the highest share due to inactive lifestyles and an upsurge in the number of people diagnosed with diabetes. Technological advancements in identifying different kinds of diseases may provide profitable opportunities, and these blood flow measurement devices assist in early diagnosis, which analyzes the treatment techniques.
The U.S follows Canada in leading the market due to the increasing number of clinical applications for invasive and non-invasive processes.
Promising Companies dominating the North America Blood Flow Measurements Devices Market Profiled in the Report are Compumedics Ltd. (Australia), Transonic Systems, Inc. (U.S.), Cook Medical, Inc. (U.S.), Perimed AB (Sweden), Medistim ASA (Norway), ADInstruments (Australia), Deltex Medical Group plc (U.K.), BIOPAC Systems, Inc. (U.S.), Atys Medical (France), SONOTEC Ultraschallsensorik Halle GmbH (Germany), and Moor Instruments Ltd. (U.K.).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Ultrasound
5.1.2.1 Ultrasound Doppler
5.1.2.2 Transit-Time Flow Meters
5.1.3 Laser Doppler
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Non-Invasive Applications
5.2.2.1 Cardiovascular Disease
5.2.2.2 Diabetes
5.2.2.3 Gastroenterology
5.2.2.4 Tumor Monitoring
5.2.2.5 Other Non-Invasive Applications
5.2.3 Invasive Applications
5.2.3.1 CABG
5.2.3.2 Microvascular Surgery
5.2.3.3 Microvascular Surgery
5.2.4 Y-o-Y Growth Analysis, By Application
5.2.5 Market Attractiveness Analysis, By Application
5.2.6 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.2 United States
6.3 Canada
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Medistim ASA
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Cook Medical, Inc.
8.3 Getinge Group
8.4 Deltex Medical Group PLC
8.5 Transonic Systems, Inc
8.6 Compumedics Limited
8.7 Adinstruments
8.8 Sonotec Ultraschallsensorik Halle GmbH
8.9 Biopac Systems Inc.
8.10 Moor Instruments Ltd.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.